Rosiglitazone and macular edema [1]

CMAJ. Canadian Medical Association Journal

Volumn 175, Issue 3, 2006, Pages 276-

  Sivagnanam, Gurusamy ^a  

^a AIMST UNIVERSITY   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ECOTHIOPATE IODIDE; INSULIN; LATANOPROST; NICOTINIC ACID; ROSIGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE;

DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; GLYCEMIC CONTROL; HUMAN; LETTER; RETINA MACULA EDEMA; RISK FACTOR; CHEMICALLY INDUCED DISORDER; DRUG CONTRAINDICATION; EDEMA; NOTE; RETINA DISEASE;

DIABETES COMPLICATIONS; EDEMA; HUMANS; RETINAL DISEASES; RISK FACTORS; THIAZOLIDINEDIONES;

EID: 33746793324     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.1060089     Document Type: Letter

References (3)

1. Kendall C, Wooltorton E. Rosiglitazone (Avandia) and macular edema. CMAJ 2006;174(5):623.
2. Roth DB. Nonpseudophakic cystoid macular edema [Internet]. In: eMedicine.com. [place unknown]: WebMD; updated 2005 May 13. Available: www.emedicine.com/oph/topic638.htm (accessed 2006 May 2).
3. Chang S. Recent developments in the treatment of diabetic macular edema. Proceedings of 11th International Conference on Health Problems Related to the Chinese; 2002 May 25-26; New York. p. 25-27. Available: www.fcmsdocs.org/ Conference/11th /Diabetic%20Macular%20Edema.pdf (accessed 2006 May 2).